VANGUARD GROUP INC – Regeneron Pharmaceuticals, Inc. Transaction History
VANGUARD GROUP INC portfolio value:
$5.95B
portfolio value
VANGUARD GROUP INC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.90% | 77.38K shares | 891.00M | $688.87 | 8.64M |
| Q2 2022 | share | Increase | +2.52% | 210.41K shares | -772.59M | $591.13 | 8.57M |
| Q1 2022 | share | Increase | +2.47% | 201.81K shares | 686.75M | $698.42 | 8.36M |
| Q4 2021 | share | Increase | +1.08% | 87.23K shares | 267.68M | $642.51 | 8.15M |
| Q3 2021 | share | Increase | +1.28% | 101.62K shares | 433.20M | $605.18 | 8.07M |
| Q2 2021 | share | Decrease | -0.38% | -30.75K shares | 666.05M | $558.54 | 7.96M |
| Q1 2021 | share | Increase | +0.87% | 69.19K shares | -46.33M | $473.14 | 8.00M |
| Q4 2020 | share | Decrease | -0.71% | -57.00K shares | -639.99M | $483.11 | 7.93M |
| Q1 2016 | share | Increase | +2.83% | 129.03K shares | -784.95M | $360.44 | 4.68M |